New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 6, 2014
08:03 EDTANIPANI Pharmaceuticals enters development agreement with Sterling Pharmaceutical
ANI Pharmaceuticals announced that it has entered into a fee-for-service development agreement for a generic drug product with Sterling Pharmaceutical Services. The product will be developed by Sterling and transferred into ANI's facilities for commercial manufacture and marketing. The current annual market for this product is $60M, according to IMS Health.
News For ANIP From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
April 14, 2015
07:05 EDTANIPNeedham to hold a conference
Subscribe for More Information
April 10, 2015
10:00 EDTANIPOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
07:42 EDTANIPANI Pharmaceuticals downgraded to Neutral from Buy at Roth Capital
Roth Capital downgraded ANI Pharmaceuticals to Neutral based on valuation.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use